anal%20fissure
ANAL FISSURE
An anal fissure is a disruption of the skin at the distal anal canal.
Most fissures are seen by separating the buttocks with opposing traction of the thumbs.
Majority of fissures are located in the posterior midline of the anus.
Acute fissures are simple splits or cracks in the anoderm while chronic fissures may show secondary changes eg sentinel tag, hypertrophied anal papilla, rolled edges, fibrosis of the edges or deep ulceration with exposure of the underlying internal anal sphincter muscle within the fissure's base.

Anal%20fissure Treatment

Principles of Therapy

Diet modification and medical therapy constitute the initial treatment for anal fissures

  • Treatment aims to relieve constipation, because softer bowel movements are less painful for the patient to pass
  • Acute fissures respond better to medical therapy better than chronic fissures

First-Line Therapy

Diet Modification

  • Patient should be placed on a high-fiber diet
  • Bran has been shown to help prevent acute fissure recurrence
  • Fluid intake should be increased

Agents to Relieve Constipation1

  • Fiber supplementation given with a high-fiber diet increases stool bulk 
  • Stool softeners eg Docusate sodium and Docusate calcium diminish bleeding and pain
  • Laxatives help maintain regular bowel movement

1Please see comprehensive list of available agents for constipation in the latest MIMS

Other Measures

  • Sitz baths relax painful internal sphincter muscle spasm
  • Topical anesthetics may be used to increase patient comfort and they cause no harm
  • Mineral oil may be used short term to minimize stretching of the anal mucosa by easing stool passage

Second-Line Therapy

  • Therapy is aimed at reversibly decreasing resting anal pressure with the goal of allowing the fissure to heal without permanent sphincter damage   
  • Second-line therapy may be used for patients wanting to avoid or who are not candidates for surgical therapy

Sphincter Relaxants

Calcium Antagonists

  • Action: Decrease resting anal pressure and anal slow and ultra-slow wave activity 
  • Eg Diltiazem, Nifedipine 
  • Topical calcium antagonists have similar rates of pain relief and healing compared with the oral forms but with lower incidence of side effects  
  • Several studies show that topical calcium antagonists appear to be as effective as treatment with topical GTN for chronic anal fissures with fewer side effects and can be utilized as 1st-line therapy 

Nitrates

  • Action: Reduce resting anal pressure and improve blood flow to the anoderm
  • Topical glyceryl trinitrate (GTN) has been shown to significantly decrease pain during treatment
  • GTN may potentiate the effect of Botulinum toxin in patients being treated for refractory fissures
  • Headache is the most common side effect and is dose related
  • The need for repeated applications may result in poor compliance and subsequent therapy failure for many patients
  • Other agents that have been studied are topical Isosorbide dinitrate ointment and spray
  • Patients unresponsive to topical nitrates should be referred for Botulinum toxin injection or surgery

Botulinum Toxin Injections

  • Action: Inhibit acetylcholine release from presynaptic nerve terminals which achieves a chemical sphincterotomy
    • At higher doses, may also transiently decrease mean squeeze pressure
  • Effect lasts about 2-3 months until nerve endings regenerate, during which time the fissure may heal
    • Healing takes longer than after surgical sphincterotomy, but return to full activity occurs sooner
  • As 2nd-line therapy after topical therapies, Botulinum toxin shows modest improvement in rates of healing, while similar results are observed when it is compared with topical treatment as 1st-line therapy for chronic anal fissures 
  • Most common side effect is transient incontinence to flatus and stool incontinence occurs less commonly
  • High cost of treatment is a disadvantage
  • Fissure recurrence after 3 months suggests that patient may benefit from surgical sphincterotomy
  • There is inadequate consensus on dosage, precise site of administration, number of injections needed, or efficacy

Other Pharmacological Agents

  • Other agents being used or studied for anal fissure include the following:
    • Muscarinic agonists eg topical Bethanechol, adrenergic antagonists eg Indoramin, and beta2-agonists eg Salbutamol
      • Topical Bethanechol is effective in healing anal fissure without significant side effects
    • Lidocaine and Hydrocortisone
Digital Edition
Asia's trusted medical magazine for healthcare professionals. Get your MIMS Gastroenterology - Malaysia digital copy today!
Sign In To Download
Editor's Recommendations
Most Read Articles
01 Dec 2020
Tetanus toxoid 5 Lf, diphtheria toxoid 2 Lf, pertussis toxoid 2.5 mcg, filamentous haemagglutinin 5 mcg, fimbriae types 2 and 3 5 mcg, pertactin 3 mcg
Dr. Hsu Li Yang, Dr. Tan Thuan Tong, Dr. Andrea Kwa, 08 Jan 2021
Antimicrobial resistance has become increasingly dire as the rapid emergence of drug resistance, especially gram-negative pathogens, has outpaced the development of new antibiotics. At a recent virtual symposium, Dr Hsu Li Yang, Vice Dean (Global Health) and Programme Leader (Infectious Diseases), NUS Saw Swee Hock School of Public Health, presented epidemiological data on multidrug-resistant (MDR) gram-negative bacteria (GNB) in Asia, while Dr Tan Thuan Tong, Head and Senior Consultant, Department of Infectious Diseases, Singapore General Hospital (SGH), focused on the role of ceftazidime-avibactam in MDR GNB infections. Dr Andrea Kwa, Assistant Director of Research, Department of Pharmacy, SGH, joined the panel in an interactive fireside chat, to discuss challenges, practical considerations, and solutions in MDR gram-negative infections. This Pfizer-sponsored symposium was chaired by Dr Ng Shin Yi, Head and Senior Consultant of Surgical Intensive Care, SGH.
Pearl Toh, 26 Nov 2020
Inhaled corticosteroid (ICS) should be the mainstay of long-term asthma management — such is the key message of the latest Singapore ACE* Clinical Guidance (ACG) for asthma, released in October 2020.
Audrey Abella, 6 days ago
A pilot telemedicine initiative may be an alternative for facilitating delivery of intravenous iron (IVI) for individuals requiring iron supplementation.